• Something wrong with this record ?

Vasodilatory responses of renal interlobular arteries to epoxyeicosatrienoic acids analog are not enhanced in Ren-2 transgenic hypertensive rats: evidence against a role of direct vascular effects of epoxyeicosatrienoic acids in progression of experimental heart failure

A. Sporková, Z. Husková, P. Škaroupková, N. Rami Reddy, J. R. Falck, J. Sadowski, L. Červenka

. 2017 ; 66 (1) : 29-39. [pub] 20161026

Language English Country Czech Republic

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc17026023

Pathophysiological mechanisms underlying the development of renal dysfunction and progression of congestive heart failure (CHF) remain poorly understood. Recent studies have revealed striking differences in the role of epoxyeicosatrienoic acids (EETs), active products of cytochrome P-450-dependent epoxygenase pathway of arachidonic acid, in the progression of aorto-caval fistula (ACF)-induced CHF between hypertensive Ren-2 renin transgenic rats (TGR) and transgene-negative normotensive Hannover Sprague-Dawley (HanSD) controls. Both ACF TGR and ACF HanSD strains exhibited marked intrarenal EETs deficiency and impairment of renal function, and in both strains chronic pharmacologic inhibition of soluble epoxide hydrolase (sEH) (which normally degrades EETs) normalized EETs levels. However, the treatment improved the survival rate and attenuated renal function impairment in ACF TGR only. Here we aimed to establish if the reported improved renal function and attenuation of progression of CHF in ACF TGR observed after she blockade depends on increased vasodilatory responsiveness of renal resistance arteries to EETs. Therefore, we examined the responses of interlobar arteries from kidneys of ACF TGR and ACF HanSD rats to EET-A, a new stable 14,15-EET analog. We found that the arteries from ACF HanSD kidneys rats exhibited greater vasodilator responses when compared to the ACF TGR arteries. Hence, reduced renal vasodilatory responsiveness cannot be responsible for the lack of beneficial effects of chronic sEH inhibition on the development of renal dysfunction and progression of CHF in ACF HanSD rats.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17026023
003      
CZ-PrNML
005      
20181001144004.0
007      
ta
008      
170824s2017 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.933350 $2 doi
035    __
$a (PubMed)27782740
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Sporková, Alexandra. $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $7 xx0239945
245    10
$a Vasodilatory responses of renal interlobular arteries to epoxyeicosatrienoic acids analog are not enhanced in Ren-2 transgenic hypertensive rats: evidence against a role of direct vascular effects of epoxyeicosatrienoic acids in progression of experimental heart failure / $c A. Sporková, Z. Husková, P. Škaroupková, N. Rami Reddy, J. R. Falck, J. Sadowski, L. Červenka
520    9_
$a Pathophysiological mechanisms underlying the development of renal dysfunction and progression of congestive heart failure (CHF) remain poorly understood. Recent studies have revealed striking differences in the role of epoxyeicosatrienoic acids (EETs), active products of cytochrome P-450-dependent epoxygenase pathway of arachidonic acid, in the progression of aorto-caval fistula (ACF)-induced CHF between hypertensive Ren-2 renin transgenic rats (TGR) and transgene-negative normotensive Hannover Sprague-Dawley (HanSD) controls. Both ACF TGR and ACF HanSD strains exhibited marked intrarenal EETs deficiency and impairment of renal function, and in both strains chronic pharmacologic inhibition of soluble epoxide hydrolase (sEH) (which normally degrades EETs) normalized EETs levels. However, the treatment improved the survival rate and attenuated renal function impairment in ACF TGR only. Here we aimed to establish if the reported improved renal function and attenuation of progression of CHF in ACF TGR observed after she blockade depends on increased vasodilatory responsiveness of renal resistance arteries to EETs. Therefore, we examined the responses of interlobar arteries from kidneys of ACF TGR and ACF HanSD rats to EET-A, a new stable 14,15-EET analog. We found that the arteries from ACF HanSD kidneys rats exhibited greater vasodilator responses when compared to the ACF TGR arteries. Hence, reduced renal vasodilatory responsiveness cannot be responsible for the lack of beneficial effects of chronic sEH inhibition on the development of renal dysfunction and progression of CHF in ACF HanSD rats.
650    _2
$a kyselina 8,11,14-eikosatrienová $x analogy a deriváty $x chemie $x farmakologie $7 D015126
650    _2
$a acetylcholin $x farmakologie $7 D000109
650    _2
$a zvířata $7 D000818
650    _2
$a progrese nemoci $7 D018450
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a srdeční selhání $x genetika $x patofyziologie $7 D006333
650    _2
$a hypertenze $x genetika $x patofyziologie $7 D006973
650    _2
$a ledviny $x krevní zásobení $x účinky léků $x fyziologie $7 D007668
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a noradrenalin $x farmakologie $7 D009638
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Sprague-Dawley $7 D017207
650    _2
$a potkani transgenní $7 D055647
650    _2
$a renální oběh $x účinky léků $x fyziologie $7 D012079
650    _2
$a renin $x fyziologie $7 D012083
650    _2
$a vazodilatace $x účinky léků $x fyziologie $7 D014664
655    _2
$a časopisecké články $7 D016428
700    1_
$a Husková, Zuzana, $d 1978- $7 xx0074206 $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Škaroupková, Petra $7 xx0117683 $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Rami Reddy, N. $u Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas, USA
700    1_
$a Falck, J. R. $u Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas, USA
700    1_
$a Sadowski, Janusz, $d 1937- $7 xx0227641 $u Department of Renal and Body Fluid Physiology, Mossakowski Medical Research Centre, Polish Academy of Science, Warsaw, Poland
700    1_
$a Červenka, Luděk, $d 1967- $7 xx0037105 $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; Department of Pathophysiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 66, č. 1 (2017), s. 29-39
856    41
$u http://www.biomed.cas.cz/physiolres/ $y stránka časopisu
910    __
$a ABA008 $b A 4120 $c 266 $y 4 $z 0
990    __
$a 20170824 $b ABA008
991    __
$a 20181001144441 $b ABA008
999    __
$a ok $b bmc $g 1246220 $s 986971
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 66 $c 1 $d 29-39 $e 20161026 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK118 $a Pubmed-20170824

Find record

Citation metrics

Archiving options